Our finding is consistent with a previously reported correlation of IL-9 concentration with worsening fatigue in men with prostate cancer after radiation [26] and chronic fatigue in patients with non-Hodgkin’s lymphoma [40]. Here, IL9 is linked to prostate carcinoma.